参考文献/References:
[1]Xu S,Ilyas I,Little PJ,et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond:from mechanism to pharmacotherapies[J]. Pharmacol Rev,2021,73(3):924-967.
[2]Dowsett L,Higgins E,Alanazi S,et al. ADMA:a key player in the relationship between vascular dysfunction and inflammation in atherosclerosis[J]. J Clin Med,2020,9(9):3026.
[3]Barvitenko N,Skverchinskaya E,Lawen A,et al. Pleiotropic and potentially beneficial effects of reactive oxygen species on the intracellular signaling pathways in endothelial cells[J]. Antioxidants (Basel) ,2021,10(6):904.
[4]Tain YL,Hsu CN. Targeting on asymmetric dimethylarginine-related nitric oxide-reactive oxygen species imbalance to reprogram the development of hypertensions[J]. Int J Mol Sci,2016,17(12):2020.
[5]Barros CDS,Livramento JB,Mouro MG,et al. L-arginine reduces nitro-oxidative stress in cultured cells with mitochondrial deficiency[J]. Nutrients,2021,13(2):534.
[6]Janaszak-Jasiecka A,Siekierzycka A,P?oska A,et al. Endothelial dysfunction driven by hypoxia—The influence of oxygen deficiency on NO bioavailability[J]. Biomolecules,2021,11(7):982.
[7]Jarzebska N,Mangoni AA,Martens-Lobenhoffer J,et al. The second life of methylarginines as cardiovascular targets[J]. Int J Mol Sci,2019,20(18):4592.
[8]Chafai A,Fromm MF,K?nig J,et al. The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1,CAT2A and CAT2B[J]. Sci Rep,2017,7(1):4767.
[9]Mohan S,Fung HL. Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine[J]. Int J Mol Sci,2012,13(6):7521-7531.
[10]Shin S,Thapa SK,Fung HL. Cellular interactions between L-arginine and asymmetric dimethylarginine:transport and metabolism[J]. PLoS One,2017,12(5):e0178710.
[11]Liang XX,Wang RY,Guo YZ,et al. Phosphorylation of Akt at Thr308 regulates p-eNOS Ser1177 during physiological conditions[J]. FEBS Open Bio,2021,11(7):1953-1964.
[12]Liu X,Xu X,Shang R,et al. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease[J]. Nitric Oxide,2018,78:113-120.
[13]Tsikas D. GC-MS and GC-MS/MS measurement of malondialdehyde (MDA) in clinical studies:pre-analytical and clinical considerations[J]. J Mass Spectrom Adv Clin Lab,2023,30:10-24.
[14]Tsikas D. Does the inhibitory action of asymmetric dimethylarginine (ADMA) on the endothelial nitric oxide synthase activity explain its importance in the cardiovascular system? The ADMA paradox[J]. J Controversies Biomed Res,2017,3(1):16-22.
[15]Janaszak-Jasiecka A,P?oska A,Wierońska JM,et al. Endothelial dysfunction due to eNOS uncoupling:molecular mechanisms as potential therapeutic targets[J]. Cell Mol Biol Lett,2023,28(1):21.
[16]Caldwell RW,Rodriguez PC,Toque HA,Narayanan SP,Caldwell RB. Arginase:a multifaceted enzyme important in health and disease[J]. Physiol Rev,2018,98(2):641-665.
[17]Ismaeel A,Papoutsi E,Miserlis D,et al. The nitric oxide system in peripheral artery disease:connection with oxidative stress and biopterins[J]. Antioxidants (Basel),2020,9(7):590.
[18]Wang Y,Zhang P,Xu Z,et al. S-nitrosylation of PDE5 increases its ubiquitin-proteasomal degradation[J]. Free Radic Biol Med,2015,86:343-351.
[19]Ragavan VN,Nair PC,Jarzebska N,et al. A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase[J]. Nat Commun,2023,14(1):3392.
[20]Zinellu A,Fois AG,Mangoni AA,et al. Systemic concentrations of asymmetric dimethylarginine (ADMA) in chronic obstructive pulmonary disease (COPD):state of the art[J]. Amino Acids,2018,50(9):1169-1176.
[21]Xiong Y,He YL,Li XM,et al. Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats[J]. Eur J Pharmacol,2021,902:174081.
[22]Luo Y,Yue W,Quan X,et al. Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease[J]. Free Radic Biol Med,2015,79:117-126.
[23]Tejero J, Shiva S, Gladwin MT. Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation[J]. Physiol Rev,2019,99(1):311-379.
[24]Gambardella J,Khondkar W,Morelli MB,et al. Arginine and endothelial function[J]. Biomedicines,2020,8(8):277.
[25]Menzel D,Haller H,Wilhelm M,et al. L-arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation[J]. Eur J Nutr,2018,57(2):557-568.
[26]Argaev-Frenkel L,Rosenzweig T. Redox balance in type 2 diabetes:therapeutic potential and the challenge of antioxidant-based therapy[J]. Antioxidants (Basel),2023,12(5):994.
[27]Doman AJ,Tommasi S,Perkins MV,et al. Chemical similarities and differences among inhibitors of nitric oxide synthase,arginase and dimethylarginine dimethylaminohydrolase-1:implications for the design of novel enzyme inhibitors modulating the nitric oxide pathway[J]. Bioorg Med Chem,2022,72:116970.
[28]Lee Y,Singh J,Scott SR,et al. A recombinant dimethylarginine dimethylaminohydrolase-1-based biotherapeutics to pharmacologically lower asymmetric dimethyl arginine,thus improving postischemic cardiac function and cardiomyocyte mitochondrial activity[J]. Mol Pharmacol,2022,101(4):226-235.
[29]Farr S,Stankovic B,Hoffman S,et al. Bile acid treatment and FXR agonism lower postprandial lipemia in mice[J]. Am J Physiol Gastrointest Liver Physiol,2020,318(4):G682-G693.
[30]Zhang X,Zheng Y,Wang Z,et al. Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases:emphasis on oxidative stress[J]. Biomed Pharmacother,2023,167:115475.
[31]Forman HJ,Zhang H. Targeting oxidative stress in disease:promise and limitations of antioxidant therapy[J]. Nat Rev Drug Discov,2021,20(9):689-709.
[32]Liao J,Lai Z,Huang G,et al. Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells[J]. Biomed Pharmacother,2024,170:116042.
[33]Chen C,Zhao JF,Hsu CP,et al. The detrimental effect of asymmetric dimethylarginine on cholesterol efflux of macrophage foam cells:role of the NOX/ROS signaling[J]. Free Radic Biol Med,2019,143:354-365.
[34]Wang C,Luo Z,Carter G,et al. NRF2 prevents hypertension,increased ADMA,microvascular oxidative stress,and dysfunction in mice with two weeks of Ang Ⅱ infusion[J]. Am J Physiol Regul Integr Comp Physiol,2018,314(3):R399-R406.
相似文献/References:
[1]张淼 魏冠平 黄煜 何庆.模拟急性高原缺氧对小鼠一氧化氮相关通路的影响[J].心血管病学进展,2020,(9):984.[doi:10.16806/j.cnki.issn.1004-3934.20.09.023]
ZHANG Miao,WEI Guanping,HUANG Yu,et al.Effect of Simulated Acute High Altitude Hypoxia on Nitric Oxide-related Pathways in Mice[J].Advances in Cardiovascular Diseases,2020,(2):984.[doi:10.16806/j.cnki.issn.1004-3934.20.09.023]
[2]于博文 修成奎 王雪 杨静 雷燕.内皮微粒在临床中的研究进展及应用[J].心血管病学进展,2021,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
YU Bowen,XIU Chengkui,WANG Xue,et al.Research Progress and Application of Endothelial Microparticles in Clinic[J].Advances in Cardiovascular Diseases,2021,(2):76.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[3]马淑青 唐其柱.氧化应激在脓毒症心肌病中的研究进展[J].心血管病学进展,2021,(2):118.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.006]
MA Shuqing,TANG Qizhu.Role of Oxidative Stress in Septic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(2):118.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.006]
[4]石玉姣 熊双 刘春秋 杨晨光 董国菊 刘剑刚.射血分数保留性心力衰竭潜在的分子机制及治疗靶点[J].心血管病学进展,2022,(5):423.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.010]
SHI Yujiao,XIONG Shuang,LIU Chunqiu,et al.Potential Molecular Mechanisms and Therapeutic Target in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(2):423.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.010]
[5]杜明亮 王泊然 惠慧 郑晓群.冠状动脉微循环功能障碍临床研究进展[J].心血管病学进展,2023,(8):699.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.007]
DU Mingliang,WANG Boran,HUI Hui,et al.Clinical Research Progress of Coronary Microcirculation Dysfunction[J].Advances in Cardiovascular Diseases,2023,(2):699.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.007]
[6]付亚萌 张光明.内质网应激与内皮功能障碍关系及临床治疗研究进展[J].心血管病学进展,2024,(3):243.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.012]
FU YamengZHANG Guangming.Research progress on the relationship between endoplasmic reticulum stress and endothelial dysfunction and its clinical treatment[J].Advances in Cardiovascular Diseases,2024,(2):243.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.012]